Skip to main content
. 2008 Sep 1;26(25):4172–4179. doi: 10.1200/JCO.2008.16.2347

Table 2.

Cycle 1 Toxicity

Toxicity Patients Grade
Toxicity Events by Dose Level (No.)
2 mg (n = 4)
3 mg (n = 3)
6 mg (n = 9)
9 mg (n = 5)
1 2 3 4 Grade 1-2 Grade 3-4 Grade 1-2 Grade 3-4 Grade 1-2 Grade 3-4 Grade 1-2 Grade 3-4
Nonhematologic
    Mucositis 4 1 2 1* 2 1 1
    Fatigue 4 4 2 2
    Pain 3 2 1 2 1
    Rash 3 3 3
    Nausea 2 2 1 1
    Diarrhea 2 1 1* 1 1
    Sinus congestion 2 2 1 1
    Anorexia 2 2 2
    Fever 2 2 1 1
    Urinary infection 1 1 1
    Sore throat 1 1 1
    Cough 1 1 1
    Edema 1 1 1
    Dyspepsia 1 1 1
    Hypertriglyceridemia 10 9 1 1 1 5 3
    Hyperglycemia 8 5 2 1* 4 1 3
    Elevated AST 7 4 3 1 4 2
    Elevated ALT 5 4 1 3 2
    Hypercholesterolemia 5 4 1 1 3 1
    Elevated AP 2 1 1 1 1
    Hypercalcemia 2 1 1 2
Hematologic
    Leukopenia 9 6 3 1 2 5 1
    Thrombocytopenia 7 6 1* 5 1 1
    Lymphopenia 6 2 4 4 2
    Anemia 6 5 1 2 3 1
    Neutropenia 3 2 1 2 1

Abbreviation: AP, alkaline phosphatase.

*

Dose-limiting toxicity.